Premium
Letter: immunogenicity of infliximab—ready for routine prediction? Authors' reply
Author(s) -
Wilson Aze,
Peel Celeste,
Wang Qian,
Pananos A. Demetri,
Kim Richard B.
Publication year - 2020
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15684
Subject(s) - immunogenicity , infliximab , medicine , biosimilar , intensive care medicine , immunology , tumor necrosis factor alpha , antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom